nelfinavir has been researched along with Cancer of Head in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buatti, JM; Gupta, AK; Lee, JH; Maity, A; Quon, H; Smith, G; Spitz, DR; Wilke, WW | 1 |
Bodeker, KL; Buatti, JM; Gupta, AK; Hoffman, HT; Milhem, MM; Robinson, RA; Taylor, EN; Wilke, WW | 1 |
Deutsch, E; Vozenin-Brotons, MC | 1 |
Bernhard, EJ; Cerniglia, GJ; Evans, SM; Gupta, AK; Hahn, SM; Jiang, Z; Koch, CJ; Maity, A; Pore, N | 1 |
4 other study(ies) available for nelfinavir and Cancer of Head
Article | Year |
---|---|
Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; ErbB Receptors; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Nelfinavir; Papillomavirus Infections; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Radiation Tolerance | 2009 |
Signaling pathways in adenoid cystic cancers: implications for treatment.
Topics: Blotting, Western; Carcinoma, Adenoid Cystic; Cell Line, Tumor; Cell Survival; ErbB Receptors; Head and Neck Neoplasms; HIV Protease Inhibitors; Humans; Immunohistochemistry; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nelfinavir; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors | 2009 |
Radiosensitivity of human papillomavirus-related tumors: in regard to Gupta et al. (Int J Radiat Oncol Biol Phys 2009;74:928-933).
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Enzyme Inhibitors; ErbB Receptors; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Nelfinavir; Papillomavirus Infections; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Radiation Tolerance | 2011 |
Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Female; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nelfinavir; Neovascularization, Pathologic; Oxygen; Protease Inhibitors; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Random Allocation; Sp1 Transcription Factor; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2006 |